A Phase II Study of Dovitinib in Recurrent and/or Metastatic Adenoid Cystic Carcinoma of the Salivary Glands (DOVE)
This study is currently recruiting participants.
Verified April 2013 by Ontario Clinical Oncology Group (OCOG)
Sponsor:
Ontario Clinical Oncology Group (OCOG)
Collaborator:
Novartis Pharmaceuticals
Information provided by (Responsible Party):
Ontario Clinical Oncology Group (OCOG)
ClinicalTrials.gov Identifier:
NCT01678105
First received: August 23, 2012
Last updated: April 19, 2013
Last verified: April 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | February 2016 |
| Estimated Primary Completion Date: | February 2014 (Final data collection date for primary outcome measure) |